Cargando…
Evaluation of DNA-Launched Virus-Like Particle Vaccines in an Immune Competent Mouse Model of Chikungunya Virus Infection
Chikungunya virus (CHIKV) infection can result in chronic and debilitating arthralgia affecting humans in tropical and subtropical regions around the world, yet there are no licensed vaccines to prevent infection. DNA launched virus like particle (VLP) vaccines represent a potentially safer alternat...
Autores principales: | Rayner, Jonathan O., Kim, Jin Hyun, Roberts, Rosemary W., Wood, Raphael Ryan, Fouty, Brian, Solodushko, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067036/ https://www.ncbi.nlm.nih.gov/pubmed/33918409 http://dx.doi.org/10.3390/vaccines9040345 |
Ejemplares similares
-
Mifepristone increases gamma-retroviral infection efficiency by enhancing integration of virus into the genome of infected cells
por: Solodushko, Victor, et al.
Publicado: (2010) -
Terminal hairpins improve protein expression in IRES-initiated mRNA in the absence of a cap and polyadenylated tail
por: Solodushko, Victor, et al.
Publicado: (2023) -
Characterization of Chikungunya Virus-Like Particles
por: Noranate, Nitchakarn, et al.
Publicado: (2014) -
Serum Can Overcome Contact Inhibition in Confluent Human Pulmonary Artery Smooth Muscle Cells
por: Solodushko, Victor, et al.
Publicado: (2013) -
Simple viral/minimal piggyBac hybrid vectors for stable production of self-inactivating gamma-retroviruses
por: Troyanovsky, Boris, et al.
Publicado: (2015)